Merck
CN

890850O

Avanti

18:1 DAP

Avanti Polar Lipids

登录to View Organizational & Contract Pricing

Select a Size

Change View
别名:
1,2-二油酰-3-二甲基铵-丙烷(DODAP)
Empirical Formula (Hill Notation):
C41H77NO4
分子量:
648.05

形式

liquid

包装

pkg of 2 × 100 mg (890850O-200mg)
pkg of 1 × 25 mg (890850O-25mg)

manufacturer/tradename

Avanti Polar Lipids

lipid type

cationic lipids
transfection

运输

dry ice

储存温度

−20°C

SMILES string

[H]C(CN(C)C)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O

比较类似商品

查看完整比较结果

显示差异

1 of 4

此商品
890850C890820P890820C
18:1 DAP Avanti Polar Lipids

Avanti

890850O

18:1 DAP

18:1 DAP Avanti Polar Lipids 890850C

Avanti

890850C

18:1 DAP

18:0 DAP Avanti Polar Lipids 890820P, powder

Avanti

890820P

18:0 DAP

18:0 DAP Avanti Polar Lipids 890820C

Avanti

890820C

18:0 DAP

packaging

pkg of 2 × 100 mg (890850O-200mg), pkg of 1 × 25 mg (890850O-25mg)

packaging

pkg of 1 × 2.5 mL (890850C-25mg), pkg of 2 × 4 mL (890850C-200mg)

packaging

pkg of 1 × 25 mg (890820P-25mg)

packaging

pkg of 1 × 2.5 mL (890820C-25mg)

manufacturer/tradename

Avanti Polar Lipids

manufacturer/tradename

Avanti Polar Lipids 890850C

manufacturer/tradename

Avanti Polar Lipids 890820P

manufacturer/tradename

Avanti Polar Lipids 890820C

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

lipid type

cationic lipids
transfection

lipid type

transfection
cationic lipids

lipid type

transfection
cationic lipids

lipid type

transfection
cationic lipids

一般描述

18:1 DAP是一种阳离子脂质,制备阳离子脂质体。

应用

18:1 DAP适用于:
  • 作为脂质双分子层的组分
  • 制备稳定的核酸脂质囊泡
  • 含反义寡脱氧核糖核苷酸(ODN)的叶酸(FA)靶向脂质体和非靶向脂质体的制备和理化特性表征

包装

5 mL透明玻璃密封安瓿瓶(890850O-200mg)
5 mL透明玻璃密封安瓿瓶(890850O-25mg)

储存分类代码

10 - Combustible liquids

WGK

WGK 3


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

Already Own This Product?

Documents related to the products that you have purchased in the past have been gathered in the Document Library for your convenience.

Visit the Document Library

Difficulty Finding Your Product Or Lot/Batch Number?

在网站页面上,产品编号会附带包装尺寸/数量一起显示(例如:T1503-25G)。请确保 在“产品编号”字段中仅输入产品编号 (示例: T1503).

示例

T1503
货号
-
25G
包装规格/数量

其它示例:

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

输入内容 1.000309185)

遇到问题?欢迎随时联系我们技术服务 寻求帮助

批号可以在产品标签上"批“ (Lot或Batch)字后面找到。

Aldrich 产品

  • 如果您查询到的批号为 TO09019TO 等,请输入去除前两位字母的批号:09019TO。

  • 如果您查询到的批号含有填充代码(例如05427ES-021),请输入去除填充代码-021的批号:05427ES。

  • 如果您查询到的批号含有填充代码(例如 STBB0728K9),请输入去除填充代码K9的批号:STBB0728。

未找到您寻找的产品?

部分情况下,可能未在线提供COA。如果搜索不到COA,可在线索取。

索取COA

其他客户在看

Slide 1 of 10

1 of 10

GL67 Avanti Polar Lipids

Avanti

890893P

GL67

18:1 TAP (DOTAP) Avanti Polar Lipids

Avanti

890890C

18:1 TAP (DOTAP)

Dioctadecylamine ≥99.0% (NT)

Sigma-Aldrich

42358

双十八烷基胺

18:0 DDAB Avanti Polar Lipids

Avanti

890810P

18:0 DDAB

18:1 (Δ9-Cis) PE (DOPE) Avanti Polar Lipids

Avanti

850725P

18:1(Δ9-顺式)PE (DOPE)

18:0 PC (DSPC) Avanti Polar Lipids

Avanti

850365P

18:0 PC (DSPC)

DC-Cholesterol HCl Avanti Polar Lipids 700001P, powder

Avanti

700001P

DC-胆固醇HCl

DMG-PEG 2000 Avanti Polar Lipids

Avanti

880151P

DMG-PEG 2000

DOTAP Liposomal Transfection Reagent >99% (TLC), liquid, suitable for transfection

Roche

11202375001

DOTAP脂质体转染试剂

18:1 (Δ9-Cis) PE (DOPE) Avanti Polar Lipids

Avanti

850725C

18:1 (Δ9-Cis) PE (DOPE)

Preparation and in-vitro evaluation of an antisense-containing cationic liposome against non-small cell lung cancer: a comparative preparation study
Saffari M, et al.
Iranian Journal of Pharmaceutical Research : IJPR, 12(Suppl), 3-3 (2013)
Transferrin-conjugated SNALPs encapsulating 2?-O-methylated miR-34a for the treatment of multiple myeloma
Scognamiglio I, et al.
BioMed Research International, 2014 (2014)
Nonequilibrium adhesion patterns at lipid bilayer junctions
Parthasarathy R, et al.
The Journal of Physical Chemistry B, 108(2), 649-657 (2004)
Qiang Cheng et al.
Nature nanotechnology, 15(4), 313-320 (2020-04-07)
CRISPR-Cas gene editing and messenger RNA-based protein replacement therapy hold tremendous potential to effectively treat disease-causing mutations with diverse cellular origin. However, it is currently impossible to rationally design nanoparticles that selectively target specific tissues. Here, we report a strategy

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门